Breakthroughs that Change Patients’ Lives
Pfizer Taiwan’s latest national honors highlight its continued role in advancing vaccine innovation, oncology treatment, and Taiwan’s broader public health resilience.
healthcare
Johnson & Johnson Connects Innovation to Patient Access for a Healthier Taiwan
Johnson & Johnson Taiwan is advancing patient access, precision diagnosis, and coordinated care to support the Healthy Taiwan vision and help more patients benefit from innovation earlier.
Moderna in Taiwan: Building an mRNA Innovation Ecosystem
Moderna Taiwan is advancing mRNA science, partnerships, and local talent development to support healthcare innovation and long-term health preparedness in Taiwan.
Where Chronic Care Is Headed: Bayer Taiwan’s Innovation Pipeline
Bayer Taiwan’s innovation pipeline reflects a broader shift in chronic care, with earlier intervention, longer-lasting treatments, and improved access helping patients manage disease more sustainably over time.
Are Jabs the Answer to Soaring Obesity Rates?
Taiwan’s growing obesity challenge is fueling interest in weight-loss medication, along with fresh questions about access, safety, and long-term care.
AstraZeneca: Building a System for the Next Generation of Care
Taiwan has built a strong reputation for broad access to innovative medicines, but the next wave of precision therapies and diagnostics will require more adaptive assessment, reimbursement, and funding pathways.
From Virology to Oncology: Gilead Sciences Expands Patient-Centered Innovation
As Gilead expands its oncology focus in Taiwan, the company is working with healthcare stakeholders to improve access to innovative therapies and support patients through increasingly complex treatment journeys.
Taiwan Makes Advances in Treatment of Pancreatic Cancer
A decade of research in Taiwan is reshaping how pancreatic cancer is detected and treated, combining innovative therapies with breakthrough AI diagnostics. These advances are opening new possibilities for earlier intervention and longer survival.
Bristol Myers Squibb’s Kris Hager on Purpose, Partnership, and Biopharma in Taiwan
Kris Hager reflects on BMS’s 60-year legacy in Taiwan and shares how integrity, inclusivity, and cross-sector collaboration shape his leadership approach and the company’s vision for driving better outcomes in Taiwan’s evolving healthcare landscape.
Roche Taiwan: Driving Innovation and Partnership for Sustainable Health Development
By expanding local R&D, advancing precision health, and advocating for a stronger innovation ecosystem, Roche Taiwan emphasizes its long-term commitment to helping Taiwan build a resilient, globally aligned healthcare system.